Role of endothelial dysfunction in coronary artery disease and implications for therapy (Q41647634)

6 October 2017

1 reference

title

Role of endothelial dysfunction in coronary artery disease and implications for therapy (English)

1 reference

6 October 2017

0 references

coronary artery disease

1 reference

S Kinlay

1

1 reference

PubMed ID

9375937

6 October 2017

P Ganz

series ordinal

2

1 reference

PubMed ID

9375937

6 October 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

American Journal of Cardiology

6 October 2017

1 reference

6 October 2017

80

1 reference

6 October 2017

9A

1 reference

6 October 2017

11I-16I

1 reference

Molecular bases of the acute coronary syndromes

6 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Coronary plaque disruption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Coronary risk factors and plaque morphology in men with coronary disease who died suddenly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Elucidation of the role of plaque instability and rupture in acute coronary events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Regression or stabilization of atherosclerosis means regression or stabilization of what we don't see in the arteriogram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Identification of an inducible endothelial-leukocyte adhesion molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Vascular endothelial cells synthesize nitric oxide from L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Contribution of nitric oxide to metabolic coronary vasodilation in the human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Nitric oxide: an endogenous modulator of leukocyte adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

In vivo EDRF activity influences platelet function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900793-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(97)00793-5

1 reference

6 October 2017

1 reference

PubMed ID

9375937